Key Speakers
• Julie Corfield, R&D Site Biobank Head, Astrazeneca
• Anne Bahr, R&D Data Privacy Coordinator, Sanofi-Aventis
• Dr. Maria Krestyaninova, Biomedical Informatics Coordinator, European Bioinformatics Institute
• Dr. Kristian Unger, Research Associate Division of Investigative Science, Imperial College London
• Kate Rolfvondenbaumen, Regulation Manager, Human Tissue Authority
• Alastair Kent, Director, Genetic Interest Group
• Dr. Alison Parry-Jones, Manager, Wales Cancer Bank
• Marc Martens, Partner, Bird & Bird LLP
• Morag McFarlane, Chief Scientific Officer, Tissue Solutions
• Dr. John Cason, Senior (Non-Clinical) Lecturer in Virology, King’s College London School of Medicine
• Dr. Michael D. Leek, Vice President, The Weinberg Group

Biobanking is changing rapidly. Biobanks are playing a vital role in today’s research and development in the fields of drug discovery and bioscience. The biobanking sector has expanded at a tremendous rate in recent years, and has also been facing many legal, financial, ethical, scientific challenges.

Visiongain is happy to announce its inaugural Biobanking Conference which will examine major trends in the biobanking industry and its changing scope. By attending Visiongain’s Biobanking conference delegates will gain an in-depth understanding of the emerging opportunities, challenges and advancements made in the field of biobanking.

Why Attend?

Key benefits
• Assess the increasing need for developing biobanks
• Understand the ethical and regulatory issues
• Implement strategies to develop a cost-effective biobank
• Examine the importance of patient involvement in biobank projects
• Learn about data protection and quality management in biobanking
• Discuss most acute and challenging scientific and policy related matters
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies

Who should attend?

VPs, Directors, Heads, Managers of:
• Biobank
• Tissue bank
• Biorepository
• Molecular Diagnostics
• Clinical Genetics, Pathology
• Histopathology
• Medical Genomics
• Non-clinical Biosample
• Data Privacy Office
• Health Science Policy
• Scientific and Quality
• Toxicology, Clinical chemistry
• Laboratory and Inventory
• R&D
• Quality Control
• Pharmacogenomics
• Procurement and Strategic Sourcing
• Strategic Outsourcing
• Clinical Research
• Translational Medicine
• Personalized Medicine,
• Bioanalytical Chemistry
• Clinical trials and Non-clinical R & D
• Pharmacogenomics
• Proteomics
• Personalised medicine
• Business development
• Strategic alliances

Others:
• Consultants& Academics
• Regulatory bodies
• Researchers